BERTUCCI, Bernardo
 Distribuzione geografica
Continente #
NA - Nord America 167
EU - Europa 151
AS - Asia 73
SA - Sud America 7
AF - Africa 1
Continente sconosciuto - Info sul continente non disponibili 1
Totale 400
Nazione #
US - Stati Uniti d'America 163
IT - Italia 76
SG - Singapore 59
DE - Germania 33
FI - Finlandia 16
GB - Regno Unito 10
BR - Brasile 7
CZ - Repubblica Ceca 4
NL - Olanda 4
SE - Svezia 4
CN - Cina 3
BD - Bangladesh 2
CA - Canada 2
IN - India 2
RU - Federazione Russa 2
TR - Turchia 2
ES - Italia 1
EU - Europa 1
FR - Francia 1
HK - Hong Kong 1
IQ - Iraq 1
KR - Corea 1
LB - Libano 1
MX - Messico 1
TT - Trinidad e Tobago 1
VN - Vietnam 1
ZA - Sudafrica 1
Totale 400
Città #
Singapore 34
Munich 29
Chandler 23
Santa Clara 15
Chicago 14
Turku 14
Carbonia 12
London 9
Milan 8
Ashburn 6
Boardman 6
Lawrence 6
Princeton 6
Ercolano 4
Olomouc 4
Rome 4
Des Moines 3
San Nicola Manfredi 3
Wilmington 3
Afragola 2
Boston 2
Grottaglie 2
Reggio Calabria 2
Settingiano 2
Verona 2
Zhengzhou 2
Alvorada 1
Bari 1
Beijing 1
Beirut 1
Benevento 1
Chaguanas 1
Charlotte 1
Chennai 1
Cosenza 1
Crestview 1
Des Plaines 1
Duhok 1
Espoo 1
Eunápolis 1
Greenville 1
Hanoi 1
Helsinki 1
Hong Kong 1
Ilsan 1
Istanbul 1
Izmir 1
Johannesburg 1
Leawood 1
Los Angeles 1
Mexico City 1
Montreal 1
Naples 1
New York 1
Norwalk 1
Norwich 1
Nuremberg 1
Oak Lawn 1
Palermo 1
Parma 1
Phoenix 1
Piracicaba 1
Redwood City 1
Reggio Emilia 1
Roccella Jonica 1
San Francisco 1
Santo Stefano di Rogliano 1
Savona 1
Settimo Torinese 1
St Petersburg 1
Suffern 1
Suri 1
São José do Rio Pardo 1
São Luís do Curu 1
São Paulo 1
Taranto 1
The Dalles 1
Tinley Park 1
Ubá 1
Totale 270
Nome #
Safety and activity of the first-in-class locked nucleic acid (LNA) miR-221 selective inhibitor in refractory advanced cancer patients: a first-in-human, phase 1, open-label, dose-escalation study 81
Clinical characteristics and predictors of mortality associated with COVID-19 in elderly patients from a long-term care facility 49
A case report of pneumomediastinum in a COVID-19 patient treated with high-flow nasal cannula and review of the literature: Is this a “spontaneous” complication? 48
miR-21 antagonism abrogates Th17 tumor promoting functions in multiple myeloma 46
Late-onset myocardial infarction and autoimmune haemolytic anaemia in a COVID-19 patient without respiratory symptoms, concomitant with a paradoxical increase in inflammatory markers: a case report 32
Differential activation of signaling pathways involved in cell death, survival and inflammation by radiocontrast media in human renal proximal tubular cells 31
An open-source covid-19 ct dataset with automatic lung tissue classification for radiomics 28
Safety and activity of the first-in-class locked nucleic acid (LNA) miR-221 selective inhibitor in refractory advanced cancer patients: a first-in-human, phase 1, open-label, dose-escalation study 25
Interleukin-62/lymphocyte as a proposed predictive index for COVID-19 patients treated with monoclonal antibodies 24
A Multicenter Retrospective Cohort Study Evaluating the Clinical Outcomes of Patients with Coagulopathy Undergoing Transcatheter Arterial Embolization (TAE) for Acute Non-Neurovascular Bleeding 22
Publisher Correction: Lessons learned and implications of early therapies for coronavirus disease in a territorial service centre in the Calabria region: a retrospective study (BMC Infectious Diseases, (2022), 22, 1, (793), 10.1186/s12879-022-07774-9) 18
Migrant cavitation as primary involvement in a particular case of granulomatosis with polyangiitis 14
RECTAL IMPACTION DUE TO PRICKLY PEAR SEEDS BEZOAR: A CASE REPORT 13
Totale 431
Categoria #
all - tutte 4.476
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.476


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202112 0 0 2 0 2 0 2 0 5 1 0 0
2021/202224 0 1 0 4 1 2 6 3 2 1 3 1
2022/202370 12 7 3 3 6 8 3 2 15 6 3 2
2023/202478 22 5 9 4 2 13 0 1 0 0 9 13
2024/2025224 20 2 0 13 16 25 10 9 17 2 50 60
2025/202623 23 0 0 0 0 0 0 0 0 0 0 0
Totale 431